Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > TNBR

<< Previous

Bullboard Posts

Next >>

Comment by lesflicson Aug 02, 2022 1:52pm

174 Views

Post# 34866253

RE:TNBR

If so, why did management need to ask for and get approval for a reverse stock split of from 1 for 10 to 1 for 20?

Gorf79 wrote: I do sling some horseshit no doubt. But that's for provocative purposes as sometimes this board offers nothing to chew on and few who'll actually do any math, let alone background homework.

Having said that I do firmly believe an FDA approval and or a Baxter takeout are near term Imminent!

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant